; (B) topic-specific research recommendations for each organ or system as impacted by fibrotic diseases described in subsection (a); and (C) an overview of common themes and specific steps for implementation. (4) To make recommendations, as appropriate, to the Director of NIH and Congress with respect to the study, evaluation, and long-range plan described in the preceding paragraphs of this subsection. (d) Operating plan Not later than 90 days after its first meeting, the Commission shall submit to the Director of NIH and the Congress an operating plan for carrying out the duties of the Commission as described in subsection (c). Such operating plan may include— (1) a list of specific activities that the Commission plans to conduct for purposes of carrying out the duties described in each of the paragraphs in subsection (c); (2) a plan for completing the activities; (3) a list of members of the Commission and other individuals who are not members of the Commission who will need to be involved to conduct such activities; (4) an explanation of NIH Institute and Center involvement and coordination needed to conduct such activities; (5) a budget for conducting such activities; and (6) other information that the Commission deems appropriate. (e) Final report Not later than 2 years after the date of the Commission’s first meeting, the Commission shall submit to the Director of NIH and the Congress a final report containing all of the findings and recommendation required by subsection (c). (f) Sunset The Commission shall terminate 60 days after submitting its final report, but not later than September 30, 2022.